Bill
SB 154
prohibit pharmaceutical manufacturers from interfering in contracts between 340B entities and pharmacies and to provide a penalty therefor.
2025 Regular Session
Introduced by Eric Emery and 10 co-sponsors
South Dakota prohibits pharmaceutical manufacturers from restricting 340B entity-pharmacy contracts, with penalties for violators, to preserve affordable drug access.
Signed by the Governor on 2025-03-13 S.J. 528